乳腺癌患者化疗所致脱发预防及护理的证据总结

doi:10.3761/j.issn.0254-1769.2021.07.020

摘要/Abstract

摘要：

目的检索、评价并整合国内外关于乳腺癌患者化疗所致脱发预防及护理的相关证据,并对最佳证据进行总结。方法系统检索UpToDate、Cochrane Library、乔安娜布里格斯研究所循证卫生保健中心数据库、British Medical Journal最佳临床实践、英国国家临床优化研究所网站、加拿大安大略护理学会网站、苏格兰校际指南网络以及美国临床肿瘤协会、肿瘤护理学会、多国癌症支持护理协会等专业协会网站中所有关于乳腺癌患者化疗所致脱发预防及护理的证据,包括指南、最佳临床实践信息册、专家共识、系统评价、证据总结,检索时限为建库至2020年12月20日。由2名研究者独立完成纳入文献的质量评价,并结合专业人士的判断,对符合标准的文献进行证据提取及总结。结果共纳入18篇文献,其中9篇指南,4篇系统评价,5篇专家共识,总结出19条最佳证据,包括多学科合作团队、评估内容、预防措施、化妆美容、心理护理、健康教育6个方面。结论乳腺癌患者化疗所致脱发预防及护理的最佳证据可为临床医护人员实践提供参考,但应结合科室环境、患者喜好选择应用最佳证据,以科学的方法管理化疗所致脱发症状,提升护理质量,提高患者的生存质量。

关键词: 乳腺肿瘤, 化疗, 脱发, 预防, 证据总结, 循证护理学

Abstract:

Objective To retrieve,evaluate and integrate domestic and foreign evidence on the prevention and nursing care of chemotherapy-induced alopecia in breast cancer patients,and to summarize the best evidence. Methods We systematically searched the evidence in databases such as UpToDate,Cochrane Library,JBI,BMJ,NICE,RNAO,SIGN,ASCO,ONS,MASCC,etc.,for high level evidence on prevention and nursing care of chemotherapy-induced alopecia in breast cancer patients,including guidelines,best practice information sheets,expert consensuses,systematic reviews and evidence summaries. The retrieval period was from the inception of databases to December 2020. Two researchers independently completed the quality evaluation of the included literature,and combining with the judgment of professionals,they extracted and summarized the evidence of the literature which the quality conformed to the standard. Results A total of 18 articles were incorporated,including 9 guidelines,4 systematic reviews and 5 expert consensuses. 19 aspects were summarized,including team building,assessment content,physical prevention,drug prevention,cosmetic,psychological care,health education and other hair changes. Conclusion The best evidence for prevention and nursing care of chemotherapy-induced alopecia in breast cancer can provide references for clinical doctors and nurses,but the best evidence should be selected according to the environment of the department and patients’ preferences. The symptoms of chemotherapy-induced alopecia should be managed in a scientific way,in order to improve the quality of nursing care and the quality of life of patients.

Key words: Breast Neoplasms, Chemotherapy, Alopecia, Prevention, Evidence Summary, Evidence-Based Nursing

肖星婷,王娴,王燕,穆文方,朱为康. 乳腺癌患者化疗所致脱发预防及护理的证据总结[J]. 中华护理杂志, 2021, 56(7): 1072-1078.

XIAO Xingting,WANG Xian,WANG Yan,MU Wenfang,ZHU Weikang. The best evidence summary for prevention and nursing care of chemotherapy-induced alopecia in breast cancer patients[J]. Chinese Journal of Nursing, 2021, 56(7): 1072-1078.

图/表 3

表1 纳入文献的一般特征

Table 1 Characteristics of included studies

表2 纳入指南的质量评价

Table 2 Quality evaluation of guidelines

表3 乳腺癌患者化疗所致脱发的预防及护理最佳证据总结

Table 3 Summary of the best evidence of the prevention and care inbreast cancer patients with chemotherapy-induced alopecia

参考文献 39

[1]	Latest global cancer data：Cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020[EB/OL]. ( 2020- 12- 15)[2020- 12- 20]. https://www.iarc.fr/fr/news-events/la-test-global-cancer-data-cancer-burden-rises-to-19-3-million-new-cases-and-10-0-million-cancer-deaths-in-2020/
[2]	Runowicz CD, Leach CR, Henry NL, et al. American cancer so-ciety/American society of clinical oncology breast cancer survivorship care guideline[J]. J Clin Oncol, 2016, 34(6):611-635. DOI PMID
[3]	褚彦香, 王颖, 熊欢. 分级管理方案在乳腺癌患者化疗所致恶心呕吐中的应用[J]. 中华护理杂志, 2019, 54(12):1815-1819.
	Chu YX, Wang Y, Xiong H. Clinical practice of grading management scheme for chemotherapy induced nausea and vomiting in breast cancer patients[J]. Chin J Nurs, 2019, 54(12):1815-1819.
[4]	王坤, 陈长英, 艾建赛, 等. 正念减压疗法对乳腺癌患者化疗期间疲乏及睡眠质量的影响[J]. 中华护理杂志, 2017, 52(5):518-523.
	Wang K, Chen CY, Ai JS, et al. The effects of mindfulness-based stress reduction on fatigue and sleep quality for breast cancer patients undergoing chemotherapy[J]. Chin J Nurs, 2017, 52(5):518-523.
[5]	Macduff C, Mackenzie T, Hutcheon A, et al. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel[J]. Eur J Cancer Care(Engl), 2003, 12(2):154-161.
[6]	Trüeb RM. Chemotherapy-induced alopecia[J]. Curr Opin Support Palliat Care, 2010, 4(4):281-284. DOI URL
[7]	Rossi A, Fortuna MC, Caro G, et al. Chemotherapy-induced alo-pecia management:clinical experience and practical advice[J]. J Cosmet Dermatol, 2017, 16(4):537-541. DOI URL
[8]	张阳, 田丽, 陈长英. 化疗致脱发对癌症病人治疗依从性的影响及护理进展[J]. 护理研究, 2017, 31(29):3643-3646.
	Zhang Y, Tian L, Chen CY. Influence and nursing progress of chemotherapy-induced alopecia on treatment compliance of cancer patients[J]. Chin Nurs Res, 2017, 31(29):3643-3646.
[9]	马玲, 王世平, Joanne Chung. 乳腺癌患者相关症状及其对生活质量的影响研究[J]. 中国循证医学杂志, 2007, 7(3):169-174.
	Ma L, Wang SP, Joanne Chung. A survey on correlative symptoms and its influence on quality of life in breast cancer patients[J]. Chin J Evid-Based Med, 2007, 7(3):169-174.
[10]	Hesketh PJ, Batchelor D, Golant M, et al. Chemotherapy-indu-ced alopecia:psychosocial impact and therapeutic approaches[J]. Support Care Cancer, 2004, 12(8):543-549. PMID
[11]	Dunnill CJ, Al-Tameemi W, Collett A, et al. A clinical and biological guide for understanding chemotherapy-induced alopecia and its prevention[J]. Oncologist, 2018, 23(1):84-96. DOI URL
[12]	Williams LA, Ginex PK, Ebanks GL, et al. ONS guidelines for cancer treatment-related skin toxicity[J]. Oncol Nurs Forum, 2020, 47(5):539-556. DOI PMID
[13]	Rugo HS, Voigt J. Scalp hypothermia for preventing alopecia during chemotherapy.A systematic review and meta-analysis of randomized controlled trials[J]. Clin Breast Cancer, 2018, 18(1):19-28. DOI URL
[14]	中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志, 2019, 29(8):609-680.
	Breast Cancer Professional Committee of Chinese Anti-Cancer Association. Guideline and standard for the diagnosis and treatment of breast cancer by Chinese anti-cancer association(2019 edition)[J]. China oncol J, 2019, 29(8):609-680.
[15]	Newhouse RP. Diffusing confusion among evidence-based prac-tice,quality improvement,and research[J]. J Nurs Adm, 2007, 37(10):432-435. DOI URL
[16]	Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ:advan-cing guideline development,reporting,and evaluation in health care[J]. Prev Med, 2010, 51(5):421-424. DOI PMID
[17]	顾莺, 张慧文, 周英凤, 等. JBI循证卫生保健中心关于不同类型研究的质量评价工具:系统评价的方法学质量评价[J]. 护士进修杂志, 2018, 33(8):701-703.
	Gu Y, Zhang HW, Zhou YF, et al. JBI evidence-based health center’s quality assessment tool for different types of research-the quality evaluation of diagnostic and economic eva-luation[J]. J Nurses Train, 2018, 33(8):701-703.
[18]	Thill M, Liedtke C, Müller V, et al. AGO recommendations for the diagnosis and treatment of patients with advanced and metastatic breast cancer:update 2018[J]. Breast Care(Basel), 2018, 13(3):209-215.
[19]	Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment:ASCO endorsement of the SIO clinical practice guideline[J]. J Clin Oncol, 2018, 36(25):2647-2655. DOI PMID
[20]	Messenger AG, McKillop J, Farrant P, et al. British Association of Dermatologists’ guidelines for the management of alopecia areata 2012[J]. Br J Dermatol, 2012, 166(5):916-926. DOI URL
[21]	Lacouture ME, Anadkat MJ, Bensadoun RJ, et al. Clinical prac-tice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities[J]. Support Care Can-cer, 2011, 19(8):1079-1095.
[22]	SIGN. Treatment of primary breast cancer[EB/OL]. ( 2013- 09- 11)[2020- 12- 20]. https://www.sign.ac.uk/our-guidelines/treatment-of-primary-breast-cancer/
[23]	Marks DH, Qureshi A, Friedman A. Evaluation of prevention interventions for taxane-induced dermatologic adverse events:a systematic review[J]. JAMA Dermatol, 2018, 154(12):1465-1472. DOI URL
[24]	Rubio-Gonzalez B, Juhász M, Fortman J, et al. Pathogenesis and treatment options for chemotherapy-induced alopecia:a systematic review[J]. Int J Dermatol, 2018, 57(12):1417-1424. DOI PMID
[25]	Shin H, Jo SJ, Kim DH, et al. Efficacy of interventions for prevention of chemotherapy-induced alopecia:a systematic review and meta-analysis[J]. Int J Cancer, 2015, 136(5):E442-E454. DOI URL
[26]	Wu Y, Li W, Stephenson M, et al. Pre-treatment assessment for patients with breast cancer undergoing chemotherapy:a best practice implementation project[J]. JBI Evid Synth, 2020, 18(1):212-223.
[27]	Cury-Martins J, Eris APM, Abdalla CMZ, et al. Management of dermatologic adverse events from cancer therapies:recommendations of an expert panel[J]. An Bras Dermatol, 2020, 95(2):221-237. DOI PMID
[28]	Chu CY, Chen KY, Wen-Cheng Chang J, et al. Taiwanese Der-matological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities[J]. J Formos Med Assoc, 2017, 116(6):413-423. DOI URL
[29]	Gutzmer R, Becker JC, Enk A, et al. Management of cutaneous side effects of EGFR inhibitors:recommendations from a German expert panel for the primary treating physician[J]. JDDG:J Der Deutschen Dermatol Gesellschaft, 2011, 9(3):195-202.
[30]	王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967.
	Wang CQ, Hu Y. JBI evidence pre-classification and evidence rank system(2014 Edition)[J]. J Nurses Train, 2015, 30(11):964-967.
[31]	Dean JC, Salmon SE, Griffith KS. Prevention of doxorubicin-induced hair loss with scalp hypothermia[J]. N Engl J Med, 1979, 301(26):1427-1429. DOI URL
[32]	Cho J, Choi EK, Kim IR, et al. Development and validation of Chemotherapy-induced Alopecia Distress Scale(CADS) for breast cancer patients[J]. Ann Oncol, 2014, 25(2):346-351. DOI PMID
[33]	张青月. 中文版乳腺癌化疗脱发困扰量表的信效度检验及其临床应用[D]. 天津:天津医科大学, 2018.
	Zhang QY. Psychometric validity and application of the Chinese version of chemotherapy-induced alopecia distress scale for breast cancer[D]. Tianjin:Tianjin Medical University, 2018.
[34]	从维莲. 化疗脱发困扰量表的汉化修订及在乳腺癌患者中的应用[D]. 广州:南方医科大学, 2020.
	Cong WL. Localization,revision and application of the chemo-therapy-induced alopecia distress scale in patients with breast cancer[D]. Guangzhou:Southern Medical University, 2020.
[35]	Prochilo T, Huscher A, Andreis F, et al. Hair loss prevention by a scalp cooling device in early breast cancer patients:the poliambulanza preliminary experience[J]. Rev Recent Clin Trials, 2019, 14(1):66-71. DOI PMID
[36]	Pliskow B, Mitra K, Kaya M. Simulation of scalp cooling by external devices for prevention of chemotherapy-induced alopecia[J]. J Therm Biol, 2016, 56:31-38. DOI URL
[37]	张青月, 李莹, 吴婷, 等. 化妆美容在乳腺癌化疗患者中的应用效果[J]. 中国护理管理, 2020, 20(4):588-592.
	Zhang QY, Li Y, Wu T, et al. Effects of cosmetic interventions on breast cancer patients undergoing chemotherapy[J]. Chin Nurs Manag, 2020, 20(4):588-592.
[38]	张佳媛, 周郁秋, 张全志, 等. 正念减压疗法对乳腺癌患者知觉压力及焦虑抑郁水平的影响[J]. 中华护理杂志, 2015, 50(2):189-193.
	Zhang JY, Zhou YQ, Zhang QZ, et al. The effect of mindfulness-based stress reduction on perceived stress,anxiety and depression in breast cancer patients[J]. Chin J Nurs, 2015, 50(2):189-193.
[39]	朱文敏, 魏小龙. 非药物干预方法对乳腺癌患者康复效果的网状Meta分析[J]. 中华护理杂志, 2020, 55(6):862-867.
	Zhu WM, Wei XL. A comparative study on the rehabilitation effects of non-pharmacological interventions in patients with Breast cancer:a network meta-analysis[J]. Chin J Nurs, 2020, 55(6):862-867.